uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Platelet-derived growth factor in primary brain tumors of neuroglial origin
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience.
1998 (English)In: Histology and Histopathology, ISSN 0213-3911, Vol. 13, no 2, 511-520 p.Article in journal (Refereed) Published
Abstract [en]

It has become clear that disruptions in the genome of somatic cells play a causative role in tumour development. We know that the ultimate formation of a malignancy is the result of a multistep process in which the functional loss and/or the altered or increased expression of genes play important roles. One such family of genes are the oncogenes, encoding protein products with mainly growth stimulating effects. Platelet-derived growth factor (PDGF) belongs to the family of oncogenes. It is likely that PDGF plays an essential role in the development of at least a subgroup of malignant astrocytic tumours that do not contain amplification of the EGF-receptor. The expression of PDGF alpha-receptors is related to tumour progression in these tumours, and some of the most malignant tumours were shown to contain amplification of the PDGF alpha-receptor. It is also clear now from several experimental studies that PDGF can drive the transformed phenotype, and that PDGF antagonists, by blocking the PDGF autocrine pathway revert the transformed phenotype of certain tumour cells. Because of the findings that receptor protein tyrosine kinases such as the EGF- and the PDGF-receptor play a crucial role in the development of gliomas, it is possible that inhibitors of the phosphorylation of the protein tyrosine kinases will be future candidates for glioma therapy. They might be able to at least delay the development of a fully malignant glioma. The role of PDGF in other tumours of neuroglial origin in the central nervous system has not been studied as extensively as its role in gliomas. Recent data suggest that also for the primitive neuroectodermal tumours overexpression of the PDGF alpha-receptor is related to malignancy of the tumours. For other tumours, such as neuroblastomas, PDGF exerts a differentiating rather than a mitogenic function and is an important survival factor. Further studies are needed to elucidate the role of PDGF in these non-glial primary brain tumours. Moreover, for a complete understanding of the role of PDGF in malignancies of the CNS, it is important to explore its function in the development of the normal CNS further.

Place, publisher, year, edition, pages
1998. Vol. 13, no 2, 511-520 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-56627PubMedID: 9589905OAI: oai:DiVA.org:uu-56627DiVA: diva2:84536
Available from: 2008-10-17 Created: 2008-10-17 Last updated: 2013-03-20Bibliographically approved

Open Access in DiVA

No full text


Search in DiVA

By author/editor
Smits, Anja
By organisation
Department of Neuroscience
In the same journal
Histology and Histopathology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 253 hits
ReferencesLink to record
Permanent link

Direct link